Nikko Asset Management Americas, Inc. Veracyte, Inc. Transaction History
Nikko Asset Management Americas, Inc.
- $8.64 Billion
- Q3 2024
A detailed history of Nikko Asset Management Americas, Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 2,746,402 shares of VCYT stock, worth $113 Million. This represents 1.08% of its overall portfolio holdings.
Number of Shares
2,746,402
Previous 3,181,592
13.68%
Holding current value
$113 Million
Previous $68.9 Million
35.56%
% of portfolio
1.08%
Previous 0.8%
Shares
25 transactions
Others Institutions Holding VCYT
# of Institutions
307Shares Held
81.7MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$319 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$318 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$206 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$202 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$174 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.93B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...